Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease

Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today announced that…

Leading UK Diagnostics Provider Source LDPath Expands AI Capabilities with Ibex Medical Analytics

 Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics and Source LDPath, a part of Source BioScience (Source), a…

Life Time Says: Have Yourself a Happy and Healthy Holiday Season by Providing Complimentary Access to Digital Content through January

To help Americans everywhere keep their health a priority during the holiday season, Life Time (NYSE:LTH), the nation’s…

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

About EIB The European Investment Bank (EIB) is the long-term lending bank of the European Union,…

Cosmetic Physician Partners (CPP) launches Network of Physician-led Medical Aesthetics Clinics across United States

Cosmetic Physician Partners Inc. (“CPP“) is pleased to announce its official launch in the US with…

Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO

Kate O’Brien, Director of the Department of Immunization, Vaccines and Biologicals at WHO Welcome to our…

Innovative Remote Health Monitoring Platform IronRod Health Received Growth Investment from HCAP Partners

HCAP Partners, a California-based private equity firm and nationally recognized impact investor, today announced its investment in…